Rafael Bañares

Full Professor

Universidad Complutense de Madrid

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rafael Bañares is a Full Professor at Universidad Complutense de Madrid, Spain. His research focuses on systemic inflammation in liver diseases, particularly in patients with acutely decompensated cirrhosis. He has published extensively on topics such as the clinical significance of HCV treatment outcomes, the efficacy of transjugular intrahepatic portosystemic shunt procedures, and the impact of Vitamin D on frailty in cirrhosis patients.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (24)

Vanesa Bernal-Monterde

SPAIN

Rafael Bañares

Research Interests

Explore related searches

Contact this professor

About

Articles (26)

Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis.

Incidence and Clinical Significance of Recompensation After HCV Cure.

Feasibility, Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis.

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.

Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty

Progressive systemic inflammation precedes decompensation in compensated cirrhosis

Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients.

Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis.

Demographic Trends in Liver Transplant Survivors After 3 Decades of Program Implementation: The Impact of Cohort and Period Effects on Life Expectancy

Dynamics of Ischemia/Reperfusion Injury Markers During Normothermic Liver Machine Perfusion.

Loss of <i>Cdkn1a</i> protects against MASLD alone or with alcohol intake by preserving lipid homeostasis.

Metabolomics as a tool to predict the risk of decompensation or liver related death in patients with compensated cirrhosis

Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.

An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting.

Pregnancy outcomes in patients with portal cavernoma: A case series study.

Hepatic hemodynamic study: More than just HVPG measurement.

Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).

Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.

<i>Akkermansia</i> deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice.

Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure

Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis.

Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study.

Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response.

Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.

Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.

Collaborators (24)

Vanesa Bernal-Monterde

Juan Gonzalez-Abraldes

Tony Bruns

Pierre‐Emmanuel Rautou

Leonard Nelson

Xavier Verhelst

Juan Turnes Vazquez

Margret Paar

Ferran Torres

Eva Roman

EDUARDO MARTINEZ-NAVES

Banwari Agarwal

ANGELA PUENTE

Minneke J. Coenraad

Laure Elkrief

Andreas Sailer

Daniel Martin

Maximilian Joseph Brol

Florence A. Castelli

Juan Carbonell-Asins

Ángela Patricia Morales Cerchiaro

Andrea De Gottardi

Jose Ignacio Fortea

Alejandro Hionides Gutierrez

Make your next move.